ARGAN INC vs FLUOR CORPORATION, two Engineering & Construction stocks. A side-by-side on valuation, growth, margins, returns, and what each price is betting.
Where AGX and FLR diverge most: on revenue growth, AGX reads +16.4% and FLR reads -8.4%; on fcf yield, AGX reads 6.0% and FLR reads -0.6%. The rest of the comparable metrics sit closer together. On valuation, today's AGX price has a different growth bar priced in than FLR (+25.3% implied for AGX vs +7.2% for FLR); the higher figure is the steeper assumption to clear, not a better or worse stock. What AGX's price implies is a somewhat stretched bet versus history (whole-company basis). The bull and bear cases for each are in their full reports below.
| Metric | AGX | FLR |
|---|---|---|
| Price | $570.06 | $50.16 |
| Market cap | $8.1B | $7.4B |
| Sector | Engineering & Construction | Engineering & Construction |
| Stage | Growth | Mature |
| Implied growth (priced in) | +25.3% | +7.2% |
| P/E | 50.1 | 22.9 |
| P/B | 17.09 | 2.52 |
| P/S | 7.77 | 0.49 |
| EV/EBITDA | 49.0 | 29.5 |
| Revenue growth | +16.4% | -8.4% |
| Gross margin | 21.0% | 0.3% |
| Operating margin | 15.6% | 2.5% |
| Net margin | 15.5% | 2.3% |
| Return on equity | 34.1% | 11.9% |
| Return on assets | 12.5% | 4.4% |
| Return on invested capital | 28.2% | 3.2% |
| FCF yield | 6.0% | -0.6% |
| Dividend yield | 0.3% | 32.4% |
| Debt / equity | 0.00 | 0.36 |
| Current ratio | 1.53 | 1.78 |
| Altman Z (solvency) | 7.78 | 8.92 |
| Piotroski F (quality) | 7 / 9 | 4 / 9 |
Each week boothcheck ranks the stocks whose prices are betting on the most. Read the most stretched bets archive →
boothcheck is also on Android. Get the app on Google Play →
The stronger value is highlighted per metric where one is strictly better on that single number; it is not an overall verdict on either company. For informational and research purposes only. Not investment advice. Not a recommendation to buy, sell, or hold any security. boothcheck is not a registered investment adviser. Past performance does not guarantee future results.